Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2008-02-27
2010-11-09
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
Reexamination Certificate
active
07829115
ABSTRACT:
The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil, olive oil, sesame seed oil, colza oil, almond oil, to the method for the preparation thereof and to the uses thereof for treating a physiological condition linked to insufficiency of progesterone secretion.
REFERENCES:
patent: 4196188 (1980-04-01), Besins
patent: 5140021 (1992-08-01), Maxson et al.
patent: 6077531 (2000-06-01), Salin-Drouin
patent: 6165491 (2000-12-01), Grasset et al.
patent: 7431941 (2008-10-01), Besins et al.
patent: 2002/0025951 (2002-02-01), Kim et al.
patent: 0253607 (1987-07-01), None
patent: 0 598 337 (1994-05-01), None
patent: WO 97/40823 (1997-11-01), None
Moneret et al.; “Food allergy to peanuts in France—evaluation of 142 observations,” Clinical and Experimental Allergy, 1998, vol. 28, pp. 1113-1119.
Dutau et al., “Les Nouveaux Allergenes Alimentaires,” Presse Medicale, 09/25/199, vol. 28, No. 28, p. 1553.
Taylor et al., “Peanut Oil is Not Allergenic to Peanut-Sensitive Individuals,” J. Allergy Clin. Immunol., 1981, vol. 68, No. 5, pp. 372-375.
Moneret-Vautrin et al., “Risks or Milk Formulas Containing Peanut Oil Contaminated with Peanut Allergens in Infants with Atopic Dermatitis,” Perdiatr. Allergy Immunol, 1994, vol. 5, pp. 184-188.
Sabbah et al., “Etude Experimentale de la Sensibilisation a I'arachide Chez Les Cobayes,” Allergie et Immunologie, 1994, vol. 26, No. 10, p. 380.
G de Montis et al., “Sensiibilisation a l'arachide et Preparations Vitaminiques en Solution Huileuse,” Arch. Pediatr., 1995, vol. 2, p. 25.
Database WPI—Derwent Publications, XP002207311—JP60258110A, “Progesterone-Emulsified Intravenous Injection—of Progesterone, Vegetable Oil, Lecithin and Opt. Benzyl-Benzoate,” Dec. 20, 1985, Daigo Eiyo Kagaku KK.
Office Action dated Nov. 25, 2005 from U.S. Appl. No. 10/495,242 (10 pgs.).
Office Action dated May 12, 2006 from U.S. Appl. No. 10/495,242 (11 pgs.).
Office Action issued Aug. 1, 2008, by the Examiner in U.S. Appl. No. 10/495,242 (US 7,431,941).
Notice of Allowance issued Jun. 11, 2008, by the Examiner in U.S. Appl. No. 10/495,242 (US 7,431,941).
Office Action issued Dec. 12, 2007, by the Examiner in U.S. Appl. No. 10/495,242 (US 7,431,941).
Office Action issued Apr. 23, 2007, by the Examiner in U.S. Appl. No. 10/495,242 (US 7,431,941).
Besins Antoine
Besse Jerome
Barham Bethany
Besins Manufacturing Belgium
Foley & Lardner LLP
Wax Robert A
LandOfFree
Pharmaceutical composition based on micronized progesterone,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition based on micronized progesterone,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition based on micronized progesterone,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187856